• LinkedIn
  • Twitter
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Advisors
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Medical Affairs
    • Market Access
    • Public Affairs
    • Devices, combination products, IVDs
    • Pharmacovigilance
    • Supply Chain
    • Legal & healthcare compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

Regulatory Affairs

Benefit from regulatory excellence across the entire lifecycle.

SFL’s leading regulatory experts provide strategic regulatory advice and hands-on operational support for drugs, biologics and advanced therapy medicinal products (ATMPs) including gene therapy products. Our experience covers all life cycle stages from development to registration and post-marketing activities.

Utilizing our Swissmedic establishment license, SME-status at EMA and a network of long-standing partners in US, Japan, Canada and other countries, SFL can act as marketing authorization applicant and MAH in Switzerland and the EU and conduct submissions to FDA, PMDA and Health Canada and other authorities.

See also SFL’s customized trainings in Regulatory Affairs for Pharma and Medtech.

  • Services

  • Regulatory Affairs
  • Quality Assurance
  • Medical Affairs
  • Market Access
  • Public Affairs
  • Devices, combination products, IVDs
  • Pharmacovigilance
  • Supply Chain
  • Legal & healthcare compliance
  • Swiss Support
  • UK Support
  • Clinical Trials support

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2022 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top